IDELVION albutrepenonacog alfa 3500 IU powder (and diluent) for injection

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

Factor IX, Quantity: 3500 IU

Disponible desde:

CSL Behring Australia Pty Ltd

formulario farmacéutico:

Solution

Composición:

Excipient Ingredients:

Vía de administración:

Intravenous

Unidades en paquete:

3500 IU

tipo de receta:

Not scheduled. Not considered by committee

indicaciones terapéuticas:

IDELVION is indicated in all patients with haemophilia B for:,? Routine prophylaxis to prevent or reduce the frequency of bleeding episodes,? Control and prevention of bleeding episodes,? Control and prevention of bleeding in the perioperative setting.

Resumen del producto:

Visual Identification: Clear solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store between 2 - 25 degrees celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estado de Autorización:

Registered

Fecha de autorización:

2020-11-19